Command Center, Inc. (CCNI) shareholder Galen Vetter, Buys $11340 in Stock; Psychemedics (PMD) Sentiment Is 0.7

Psychemedics Corporation (NASDAQ:PMD) Logo

Sentiment for Psychemedics Corp (PMD)

Psychemedics Corp (PMD) investors sentiment decreased to 0.7 in Q1 2018. It’s down -0.25, from 0.95 in 2017Q4. The ratio dived, as 14 hedge funds started new and increased stock positions, while 20 decreased and sold their holdings in Psychemedics Corp. The hedge funds in our database reported: 2.83 million shares, up from 2.83 million shares in 2017Q4. Also, the number of hedge funds holding Psychemedics Corp in top ten stock positions was flat from 1 to 1 for the same number . Sold All: 2 Reduced: 18 Increased: 5 New Position: 9.

Another recent and important Psychemedics Corporation (NASDAQ:PMD) news was published by which published an article titled: “Psychemedics: Significant Revenue Catalyst In September” on May 30, 2018.

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company has market cap of $109.79 million. The companyÂ’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It has a 18.17 P/E ratio. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine.

Tieton Capital Management Llc holds 5.51% of its portfolio in Psychemedics Corporation for 281,222 shares. Moors & Cabot Inc. owns 377,279 shares or 1.07% of their US portfolio. Moreover, Mill Road Capital Management Llc has 0.56% invested in the company for 32,568 shares. The California-based Quantum Capital Management has invested 0.24% in the stock. North Star Investment Management Corp., a Illinois-based fund reported 81,194 shares.

Since January 1, 0001, it had 0 buys, and 1 sale for $98,243 activity.

The stock increased 3.04% or $0.59 during the last trading session, reaching $19.99. About 13,202 shares traded or 44.13% up from the average. Psychemedics Corporation (PMD) has declined 2.67% since June 13, 2017 and is downtrending. It has underperformed by 15.24% the S&P500. Some Historical PMD News: ; 22/04/2018 – DJ Psychemedics Corporation, Inst Holders, 1Q 2018 (PMD); 02/05/2018 – Psychemedics Corporation Announces New Vice President, Sales and Marketing; 24/04/2018 – Psychemedics 1Q EPS 23c; 24/04/2018 – Psychemedics Announces 1Q Record Revenues and Dividend Increase of 20%; 07/03/2018 Psychemedics 4Q EPS 42c; 08/05/2018 – James Abely Promoted to VP and General Counsel at Psychemedics Corporation; 14/05/2018 – Kennedy Capital Incorporated Buys 1% Position in Psychemedics; 24/04/2018 – PSYCHEMEDICS CORP PMD.O SETS QUARTERLY DIVIDEND OF $0.18/SHR

It closed at $5.55 lastly. It is up 0.00% since June 13, 2017 and is . It has underperformed by 12.57% the S&P500.

Not a long ago, the shareholder of Command Center Inc, Mr. Galen Vetter, made a purchase of 2,000 shares, totalling $11,340 USD, estimated based on $5.7 per each share. Presently, Galen Vetter owns 2,556 shares which make up roughly 0.05% of the Company’s total market capitalization.

Psychemedics Corporation (NASDAQ:PMD) Institutional Positions Chart